JP2023510603A5 - - Google Patents
Info
- Publication number
- JP2023510603A5 JP2023510603A5 JP2022543410A JP2022543410A JP2023510603A5 JP 2023510603 A5 JP2023510603 A5 JP 2023510603A5 JP 2022543410 A JP2022543410 A JP 2022543410A JP 2022543410 A JP2022543410 A JP 2022543410A JP 2023510603 A5 JP2023510603 A5 JP 2023510603A5
- Authority
- JP
- Japan
- Prior art keywords
- amyloid
- chimeric receptor
- domain
- receptor according
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062962763P | 2020-01-17 | 2020-01-17 | |
| US62/962,763 | 2020-01-17 | ||
| PCT/US2021/013727 WO2021146620A2 (en) | 2020-01-17 | 2021-01-15 | Chimeric antigen receptors for removal of amyloid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023510603A JP2023510603A (ja) | 2023-03-14 |
| JP2023510603A5 true JP2023510603A5 (enExample) | 2024-01-23 |
Family
ID=76864318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022543410A Pending JP2023510603A (ja) | 2020-01-17 | 2021-01-15 | アミロイド除去のためのキメラ抗原受容体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230068507A1 (enExample) |
| EP (1) | EP4090362A4 (enExample) |
| JP (1) | JP2023510603A (enExample) |
| KR (1) | KR20220129026A (enExample) |
| CN (1) | CN115175693A (enExample) |
| AU (1) | AU2021208630A1 (enExample) |
| BR (1) | BR112022013940A2 (enExample) |
| CA (1) | CA3164691A1 (enExample) |
| IL (1) | IL294740A (enExample) |
| MX (1) | MX2022008687A (enExample) |
| WO (1) | WO2021146620A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109553686A (zh) * | 2017-09-26 | 2019-04-02 | 南京安吉生物科技有限公司 | 一种新型可调控的双嵌合抗原受体t细胞及其构建方法和应用 |
| WO2022120378A1 (en) * | 2020-12-04 | 2022-06-09 | University Of Tennessee Research Foundation | Method for diagnosing amyloid diseases |
| WO2024050478A1 (en) * | 2022-09-02 | 2024-03-07 | University Of Tennessee Research Foundation | Chimeric antigen receptors for removal of amyloid |
| SE548109C2 (en) * | 2023-03-28 | 2026-03-30 | Cerimmune Therapeutics Ab | Microglial endocytic receptors for use in the treatment of neurodegenerative disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2173381B1 (en) * | 2007-05-14 | 2013-10-02 | NovImmune SA | Fc receptor-binding polypeptides with modified effector functions |
| JP2017528449A (ja) * | 2014-08-26 | 2017-09-28 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | アミロイドーシスのための標的化免疫療法 |
| US20180186855A1 (en) * | 2016-03-23 | 2018-07-05 | Alector Llc | Chimeric receptors and methods of use thereof |
| MX2019015914A (es) * | 2017-06-29 | 2020-08-06 | Univ Columbia | Anticuerpos quiméricos para el tratamiento de enfermedades por deposición de amiloide. |
| US11382974B2 (en) * | 2017-08-01 | 2022-07-12 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for treatment of amyloid deposition diseases |
| CN109837246A (zh) * | 2017-11-25 | 2019-06-04 | 深圳宾德生物技术有限公司 | 一种敲除pd1的靶向ror1的嵌合抗原受体t细胞及其制备方法和应用 |
| AU2019215110B2 (en) * | 2018-02-02 | 2024-07-25 | The Trustees Of The University Of Pennsylvania | Modified monocytes/macrophages/dendritic cells expressing chimeric antigen receptors and uses in diseases and disorders associated with protein aggregates |
| US11246513B2 (en) * | 2018-02-08 | 2022-02-15 | Senseonics, Incorporated | Data management system communications with a display device in an analyte monitoring system |
-
2021
- 2021-01-15 WO PCT/US2021/013727 patent/WO2021146620A2/en not_active Ceased
- 2021-01-15 EP EP21741748.4A patent/EP4090362A4/en not_active Withdrawn
- 2021-01-15 US US17/793,355 patent/US20230068507A1/en active Pending
- 2021-01-15 KR KR1020227027772A patent/KR20220129026A/ko not_active Ceased
- 2021-01-15 JP JP2022543410A patent/JP2023510603A/ja active Pending
- 2021-01-15 CN CN202180015824.4A patent/CN115175693A/zh active Pending
- 2021-01-15 AU AU2021208630A patent/AU2021208630A1/en active Pending
- 2021-01-15 CA CA3164691A patent/CA3164691A1/en active Pending
- 2021-01-15 MX MX2022008687A patent/MX2022008687A/es unknown
- 2021-01-15 BR BR112022013940A patent/BR112022013940A2/pt unknown
-
2022
- 2022-07-13 IL IL294740A patent/IL294740A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019535268A5 (ja) | アクチビンＩＩａ型受容体変異体および同変異体を含む医薬組成物 | |
| JP2020519298A5 (enExample) | ||
| JP2023518596A5 (enExample) | ||
| JP2023504172A5 (enExample) | ||
| JP2018171063A5 (enExample) | ||
| JP2016533174A5 (enExample) | ||
| JP2019514361A5 (enExample) | ||
| JP2019521643A5 (enExample) | ||
| JP2019531055A5 (enExample) | ||
| JP2019501647A5 (enExample) | ||
| JP2016000731A5 (enExample) | ||
| JP2023528207A5 (enExample) | ||
| CA2561826A1 (en) | Linear single chain recombinant anti-cea/cd3/cd28 trispecific antibody | |
| JP2016528295A5 (enExample) | ||
| JP2019519227A5 (enExample) | ||
| JP2018537087A5 (enExample) | ||
| JP2019514367A5 (enExample) | ||
| JP2010254694A5 (enExample) | ||
| JP2009201525A5 (enExample) | ||
| JP2019506166A5 (enExample) | ||
| WO2009142773A4 (en) | Multivalent fibronectin based scaffold domain proteins | |
| JP2009529509A5 (enExample) | ||
| JP2021518151A5 (enExample) | ||
| HRP20210635T1 (hr) | Novi mutant humanog seruma albumina | |
| FI4034555T3 (fi) | Dap10/dap12-fuusiopolypeptidit |